Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma

Bone Marrow Transplantation

Volumn 44, Issue 5, 2009, Pages 287-293

  Sohn, B S ^a   Park, I ^a   Kim, E K ^a   Yoon, D H ^a   Lee, S S ^a   Kang, B W ^a   Jang, G ^a   Choi, Y H ^a   Kim, C ^a   Lee, D H ^a   Kim, S ^a   Huh, J ^a   Suh, C ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IBRITUMOMAB TIUXETAN; IFOSFAMIDE; LACTATE DEHYDROGENASE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; HUMAN; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SEX DIFFERENCE; SURVIVAL TIME; T CELL LYMPHOMA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349107255     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.29     Document Type: Article

References (27)

1. Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U et al Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474-2479.
2. Au WY, Liang R. Peripheral T-cell lymphoma. Curr Oncol Rep 2002; 4: 434-442.
3. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
4. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
5. Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998; 83: 806-812.
6. Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American Lymphoma (REAL) classification. Eur J Cancer 2002; 38: 75-81.
7. Tomita N, Motomura S, Hyo R, Takasaki H, Takemura S, Taguchi J et al Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma. Cancer 2007; 109: 1146-1151.
8. Kojima H, Hasegawa Y, Suzukawa K, Mukai HY, Kaneko S, Kobayashi T et al. Clinicopathological features and prognostic factors of Japanese patients with 'peripheral T-cell lymphoma, unspecified' diagnosed according to the WHO classification. Leuk Res 2004; 28: 1287-1292.
9. Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol 1990; 1: 45-50.
10. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76-82.
11. Lopez-Guillermo A, Cid J, Salar A, Lopez A, Montalban C, Castrillo JM et al. Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification. Ann Oncol 1998; 9: 849-855.
12. Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89: 4514-4520.
13. Pellatt J, Sweetenham J, Pickering RM, Brown L, Wilkins B. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma. Ann Hematol 2002; 81: 267-272.
14. Reiser M, Josting A, Soltani M, Staib P, Salzberger B, Diehl V et al T-cell non-Hodgkin's lymphoma in adults: Clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma 2002; 43: 805-811.
15. Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, Neri S et al. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: Experience of the Intergruppo Italiano Linformi. Cancer 2004; 101: 1601-1608.
16. Kahl C, Leithauser M, Wolff D, Steiner B, Hartung G, Casper J et al Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Ann Hematol 2002; 81: 646-650.
17. Mounier N, Gisselbrecht C, Briere J, Haioun C, Feugier P, Offner F et al. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: A cohort study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2004; 22: 2826-2834.
18. Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533-1538.
19. Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997; 15: 1131-1137.
20. Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J et al Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: A prospective study from The Gel-Tamo Study Group. Eur J Haematol 2007; 79: 32-38.
21. Rodriguez J, Conde E, Gutierrez A, Lahuerta JJ, Arranz R, Sureda A et al. The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma. Haematologica 2007; 92: 1067-1074.
22. Song KW, Mollee P, Keating A, Crump M. Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: Variable outcome according to pathological subtype. Br J Haematol 2003; 120: 978-985.
23. Zaja F, Russo D, Silvestri F, Fanin R, Damiani D, Infanti L et al. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: Clinical characteristics and outcome. Haematologica 1997; 82: 171-177.
24. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
25. Mounier N, Gisselbrecht C, Briere J, Haioun C, Feugier P, Offner F et al. All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: A matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Ann Oncol 2004; 15: 1790-1797.
26. Kim MK, Kim S, Lee SS, Sym SJ, Lee DH, Jang S et al. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: Complete response at transplant predicts survival. Ann Hematol 2007; 86: 435-442.
27. Lee SS, Cho KJ, Kim CW, Kang YK. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology 1999; 35: 345-354.